Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LCTX compared with IMDX: revenue, margins and what each company keeps, and the suppliers and customers both name
LCTX
Lineage Cell Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
IMDX
Insight Molecular Diagnostics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LCTX
Lineage Cell Therapeutics, Inc.
vs
IMDX
Insight Molecular Diagnostics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LCTX: latest quarter not drawable. IMDX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LCTX
12
—
Cell Cure Neurosciences Ltd. (CCN)
unlisted
supplier
—
Hadasit
unlisted
supplier
—
Cancer Research Technology (CRT)
unlisted
supplier
—
Israel Innovation Authority (IIA)
unlisted
supplier
8 more · LCTX chain
›
Shared
0
No shared counterparties.
Only IMDX
2
BIO
Bio-Rad Laboratories
supplier
—
Chronix
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LCTX, solid
IMDX, dashed
LCTX
Lineage Cell Therapeutics, Inc.
Change
1.01
▼
−2.30%
· post 1.01
Mkt cap
$252.9M
Revenue
$1M
Q2 FY26
Revenue
$15M
FY25
IMDX
Insight Molecular Diagnostics Inc.
Change
2.97
▼
−6.51%
· post 2.97
Closed
Oct 30 '26
Mkt cap
$96.9M
Revenue
$239,000
Q2 FY26
Revenue
$4M
FY25
vs
Compare
Closed
Oct 30 '26
LCTX
Lineage Cell Therapeutics, Inc.
vs
IMDX
Insight Molecular Diagnostics Inc.
1.01
▼
−2.30%
post 1.01
Price
2.97
▼
−6.51%
post 2.97
$252.9M
Mkt cap
$96.9M
Q2 FY26
$1M
Revenue
$239,000
Q2 FY26
FY25
$15M
Revenue
$4M
FY25
Change
Change
LCTX
1.01
▼
−2.30%
vs
IMDX
2.97
▼
−6.51%
Closed
Oct 30 '26